Skip to main content

Table 2 Pooled prevalence of S. aureus resistance to different antibiotics in Nigeria

From: A meta-analysis on the prevalence of resistance of Staphylococcus aureus to different antibiotics in Nigeria

Antibiotics

No. of studies

Total No. of isolates

No. of resistant isolates

Pooled AMR prevalence (95% CI)

I2(P-value) (P ≤ 0.01)

Vancomycin

29

2546

340

0.13 (0.7, 0.21)

96.60

Methicilin

30

3109

1445

0.46 (0.37, 0.56)

96.71

Ciprofloxacin

44

2739

838

0.31 (0.24, 0.38)

93.85

Tetracycline

43

3359

2170

0.65 (0.56, 0.76)

96.03

Cotrimoxazole

21

1293

855

0.66 (0.55, 0.76)

93.91

Chloramphenicol

32

2015

943

0.47 (0.37, 0.56)

95.03

Erythromycin

66

4969

2325

0.47 (0.40, 0.53)

95.31

Penicillin

15

1709

1396

0.82 (0.61, 0.96)

98.97

Clindamycin

12

787

275

0.35 (0.23, 0.49)

93.26

Amoxicillin

40

2167

1614

0.74 (0.66, 0.81)

94.64

Ampicillin

28

2074

1408

0.68 (0.53, 0.81)

97.91

Gentamycin

77

5470

1701

0.31 (0.25, 0.37)

95.90

Ceftriaxone

25

2144

943

0.44 (0.34, 0.54)

95.64

Amoxicillin/clavulanic acid

20

1665

1032

0.62 (0.50, 0.73)

95.76

Ceftazidim

24

2179

1329

0.61 (0.46, 0.75)

98.01

Cefuroxime

17

1035

714

0.69 (0.51, 0.85)

97.23

Cloxacillin

22

1565

1205

0.77 (0.64, 0.88)

97.13

Norfloxacillin

9

491

162

0.33 (0.17, 0.52)

95.27

Rifampicin

7

302

72

0.24 (0.06, 0.48)

95.19

Streptomycin

20

1287

579

0.45 (0.34, 0.57)

94.08

Ofloxacin

25

2058

494

0.24 (0.18, 0.31)

91.63

Trimethoprim

6

291

160

0.55 (0.35, 0.74)

91.99

Cefoxitine

21

1791

770

0.43 (0.31, 0.56)

96.61